Rare diseases
Investigational molecules
Locations
Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia
SlovakiaEfficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia
SlovakiaEfficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes
SlovakiaEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
SlovakiaEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
SlovakiaA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
SlovakiaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
SlovakiaEfficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial
SlovakiaPhase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)
SlovakiaA Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration
SlovakiaLong‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis
SlovakiaA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
SlovakiaTell us about your condition – we search every trial in Europe and connect you with the right site.
